FDA

Pulmonary Arterial Hypertension Could Help Liquidia Technologies Stock Rise Over 300%
A new research report outlines favorable Liquidia Technologies drug study data that will be presented in the coming weeks, which could add up to more than 300% potential upside.
Jon C. Ogg
3 days ago

5 FDA COVID-19 Decisions in July Could Make or Break Stocks
Here is a look of a few of the biggest clinical trial and FDA updates to watch for in July 2020.
Chris Lange
7 days ago

Why 'Positive Results' in Coronavirus Are Not Good Enough for Inovio Pharma
While COVID-19 pandemic is not its only target, that has been the main driver of the interest in Inovio Pharmaceuticals so far in 2020.
Jon C. Ogg
10 days ago

Why This Parkinson's Study Could Be Huge
Alterity Therapeutics says it has received an update from the FDA regarding its Parkinson’s treatment. That made shareholders happy.
Chris Lange
10 days ago

What This FDA Update Means for Intercept Pharma
Intercept Pharmaceuticals stock was crushed early on Monday after the firm received an update from the FDA in regards to its treatment of fibrosis due to nonalcoholoic steatohepatitis.
Chris Lange
11 days ago

Another Speculative COVID-19 Stock Bites the Dust
Whenever there are new emerging trends, many companies try to get in on the action. It can create a flurry of interest from businesses and from investors alike, and to say that the coronavirus and...
Jon C. Ogg
23 days ago

Aclaris Therapeutics Takes the Next Big Step Toward COVID Treatment
Aclaris Therapeutics has received an update from FDA regarding the use of its ATI-450 in hospitalized patients with COVID-19.
Chris Lange
23 days ago

Can the 800% Gain in Immuron Be Rationalized Very Easily?
The day traders are back at it, chasing stocks on news with very few thoughts about what the fundamentals may be if the good news pans out. In day trading, that just doesn’t matter because a...
Jon C. Ogg
1 month ago
Last Updated: 1 month ago

Enochian Bio's HIV Treatment Is on Its Way With the FDA
Enochian Biosciences shares more than doubled to start out the week after the company received a critical update from the FDA regarding its HIV treatment.
Chris Lange
1 month ago

Why This COVID-19 Stock More Than Tripled
FSD Pharma shares absolutely exploded on Wednesday morning after the company received a key update from the FDA.
Chris Lange
1 month ago

The FDA's Newest Nod for a Coronavirus Treatment Trial
PhaseBio Pharmaceuticals shares jumped early on Thursday after the company announced that it received an authorization from the FDA regarding its COVID-19 treatment.
Chris Lange
1 month ago

Diffusion Pharma's COVID-19 Treatment Takes a Big Step Forward With the FDA
Diffusion Pharmaceuticals shares pushed higher to start the week after it announced a critical update from the FDA concerning its potential treatment for COVID-19 patients displaying severe...
Chris Lange
1 month ago

Will This COVID-19 Treatment for Cancer Patients Be a Big Hit?
AIM ImmunoTech shares ticked higher on Thursday after the company announced some big developments with the FDA concerning its treatment for cancer patients with COVID-19.
Chris Lange
1 month ago

Why This FDA Update Is Huge for Applied DNA Sciences
Applied DNA Sciences shares made an incredible gain on Thursday after the company announced it had received an update from the FDA concerning its COVID-19 assay kit.
Chris Lange
1 month ago

What's Next for CymaBay's NASH Study
CymaBay Therapeutics shares more than doubled on Tuesday after the company announced its first-quarter results, along with a corporate update.
Chris Lange
1 month ago